Abpro Holdings (ABPO) Prepaid Assets (2022 - 2026)
Abpro Holdings' (ABPO) quarterly Prepaid Assets came in at $1.0 million in Q1 2026, up 117.39% YoY from $483000.0 in Q1 2025, and up 118.75% on a QoQ basis from $480000.0 in Q4 2025.
Abpro Holdings (ABPO) Prepaid Assets (2022 - 2026) Analysis & Trends
Abpro Holdings (ABPO) has 5 years of Prepaid Assets data on file, last reported at $1.0 million in Q1 2026.
- Quarterly Prepaid Assets rose 117.39% year-over-year to $1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.0 million (up 117.39% YoY) and the FY2025 annual result came in at $480000.0, up 7.62% from the prior year.
- Prepaid Assets advanced to $1.0 million in Q1 2026, from $480000.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $1.0 million in Q1 2026 to a low of $15143.0 in Q1 2024.
- A 5-year average of $403769.0 and a median of $446000.0 in 2024 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2024 — Prepaid Assets slumped 94.54% — and 2025, when it jumped 3089.59%.
- Tracing ABPO's Prepaid Assets over 5 years: stood at $377780.0 in 2022, then plunged by 44.94% to $208000.0 in 2023, then surged by 114.42% to $446000.0 in 2024, then gained by 7.62% to $480000.0 in 2025, then jumped by 118.75% to $1.0 million in 2026.
- The last three Prepaid Assets figures came in at $1.0 million (Q1 2026), $480000.0 (Q4 2025), and $611000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Abpro Holdings | 1.14 Mn | 1.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.05 Mn |
| Dec 31, 2025 | 480,000.00 |
| Sep 30, 2025 | 611,000.00 |
| Jun 30, 2025 | 697,000.00 |
| Mar 31, 2025 | 483,000.00 |
| Dec 31, 2024 | 446,000.00 |
| Sep 30, 2024 | 20,250.00 |
| Jun 30, 2024 | 40,500.00 |
| Mar 31, 2024 | 15,143.00 |
| Dec 31, 2023 | 208,000.00 |
| Sep 30, 2023 | 105,635.00 |
| Jun 30, 2023 | 217,623.00 |
| Mar 31, 2023 | 277,209.00 |
| Dec 31, 2022 | 377,780.00 |
| Sep 30, 2022 | 489,935.00 |
| Jun 30, 2022 | 609,959.00 |
| Mar 31, 2022 | 735,039.00 |